| Functional attributes of antibodies, effector cells, and target cells affecting NK cell–mediated antibody-dependent cellular cytotoxicity AR Temming, SW de Taeye, EL de Graaf, LA de Neef, G Dekkers, ... The Journal of Immunology 203 (12), 3126-3135, 2019 | 75 | 2019 |
| Unique patterns of glycosylation in immunoglobulin subclass G4‐related disease and primary sclerosing cholangitis EL Culver, FS van de Bovenkamp, NIL Derksen, J Koers, T Cargill, ... Journal of gastroenterology and hepatology 34 (10), 1878-1886, 2019 | 36 | 2019 |
| Clinically relevant discrepancies between different rheumatoid factor assays WJJ Falkenburg, HJ Von Richthofen, J Koers, C Weykamp, MWJ Schreurs, ... Clinical Chemistry and Laboratory Medicine (CCLM) 56 (10), 1749-1758, 2018 | 28 | 2018 |
| Biased N-glycosylation site distribution and acquisition across the antibody V region during B cell maturation J Koers, NIL Derksen, P Ooijevaar-de Heer, B Nota, ... The Journal of Immunology 202 (8), 2220-2228, 2019 | 27 | 2019 |
| Differences in IgG autoantibody Fab glycosylation across autoimmune diseases J Koers, R Sciarrillo, NIL Derksen, EM Vletter, YE Fillié-Grijpma, ... Journal of Allergy and Clinical Immunology 151 (6), 1646-1654, 2023 | 14 | 2023 |
| Identification of clinically and pathophysiologically relevant rheumatoid factor epitopes by engineered IgG targets WJJ Falkenburg, N Oskam, J Koers, L van Boheemen, ... Arthritis & Rheumatology 72 (12), 2005-2016, 2020 | 14 | 2020 |
| Elevated Fab glycosylation of anti-hinge antibodies J Koers, NIL Derksen, WJJ Falkenburg, P Ooijevaar-de Heer, ... Scandinavian Journal of Rheumatology 52 (1), 25-32, 2023 | 6 | 2023 |
| CD45RB glycosylation and ig isotype define maturation of functionally distinct b cell subsets in human peripheral blood J Koers, S Pollastro, S Tol, I Pico-Knijnenburg, NIL Derksen, ... Frontiers in immunology 13, 891316, 2022 | 6 | 2022 |
| Optimized protocols for in-vitro T-cell-dependent and T-cell-independent activation for B-cell differentiation studies using limited cells C Marsman, D Verhoeven, J Koers, T Rispens, A Ten Brinke, ... Frontiers in immunology 13, 815449, 2022 | 4 | 2022 |
| Oxygen level is a critical regulator of human B cell differentiation and IgG class switch recombination J Koers, C Marsman, J Steuten, S Tol, NIL Derksen, A Ten Brinke, ... Frontiers in immunology 13, 1082154, 2022 | 2 | 2022 |
| Improving naive B cell isolation by absence of CD45RB glycosylation and CD27 expression in combination with BCR isotype J Koers, S Pollastro, S Tol, ITG Niewold, PA van Schouwenburg, ... European journal of immunology 52 (10), 1630-1639, 2022 | 1 | 2022 |
| Rheumatoid factors may potentiate immune complex formation of anti-citrullinated protein antibodies WJJ Falkenburg, D van Schaardenburg, J Koers, P Ooijevaar-de Heer, ... ARTHRITIS & RHEUMATOLOGY 68, 2016 | 1 | 2016 |
| B cell and antibody differentiation: The contribution of glycans to repertoire diversification and classification J Koers | | 2023 |
| Pronounced (intrinsic) differences in N-glycosylation sites located in the variable domain of Igκ and Igλ light chains in ACPA-expressing B cells RD Vergroesen, LM Slot, J Koers, S Reijm Putting the pieces together, 123, 2022 | | 2022 |
| Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis FS van de Bovenkamp, EL Culver, NIL Derksen, J Koers, T Cargill, ... The role of variable domain glycosylation of antibodies in immunity, 135, 2018 | | 2018 |
| SAT0017 The rheumatoid factor response is composed of multiple reactivities against different epitopes W Falkenburg, J Koers, P Oijevaar-de Heer, D van Schaardenburg, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 876-877, 2018 | | 2018 |
| AB0082 Clinically relevant discrepancies between different rheumatoid factor assays W Falkenburg, H von Richthofen, J Koers, C Weykamp, M Schreurs, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 1238-1238, 2018 | | 2018 |
